Beacon Pharmaceuticals (DHA:BEACONPHAR) EV-to-Revenue : 5.51 (As of May. 02, 2024)

View and export this data going back to 2010. Start your Free Trial

What is Beacon Pharmaceuticals EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Beacon Pharmaceuticals's enterprise value is BDT51,787 Mil. Beacon Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was BDT9,402 Mil. Therefore, Beacon Pharmaceuticals's EV-to-Revenue for today is 5.51.

The historical rank and industry rank for Beacon Pharmaceuticals's EV-to-Revenue or its related term are showing as below:

DHA:BEACONPHAR' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.18 Med: 6.31 Max: 11.83
Current: 5.51

During the past 8 years, the highest EV-to-Revenue of Beacon Pharmaceuticals was 11.83. The lowest was 1.18. And the median was 6.31.

DHA:BEACONPHAR's EV-to-Revenue is ranked worse than
78.13% of 1024 companies
in the Drug Manufacturers industry
Industry Median: 2.35 vs DHA:BEACONPHAR: 5.51

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-02), Beacon Pharmaceuticals's stock price is BDT187.20. Beacon Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was BDT40.70. Therefore, Beacon Pharmaceuticals's PS Ratio for today is 4.60.

Beacon Pharmaceuticals EV-to-Revenue Historical Data

The historical data trend for Beacon Pharmaceuticals's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beacon Pharmaceuticals EV-to-Revenue Chart

Beacon Pharmaceuticals Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

EV-to-Revenue

Get a 7-Day Free Trial

1.32

2.79

4.31

7.85

7.47

Beacon Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															8.90	8.05	7.47	7.26	6.93

Competitive Comparison of Beacon Pharmaceuticals's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Beacon Pharmaceuticals's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beacon Pharmaceuticals's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beacon Pharmaceuticals's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Beacon Pharmaceuticals's EV-to-Revenue falls into.

Beacon Pharmaceuticals EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Beacon Pharmaceuticals's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	51787.366	/	9402.244
	=	5.51

Beacon Pharmaceuticals's current Enterprise Value is BDT51,787 Mil.
Beacon Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT9,402 Mil.

Beacon Pharmaceuticals (DHA:BEACONPHAR) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Beacon Pharmaceuticals's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	187.20	/	40.703
	=	4.60

Beacon Pharmaceuticals's share price for today is BDT187.20.
Beacon Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT40.70.

Beacon Pharmaceuticals EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Beacon Pharmaceuticals's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Beacon Pharmaceuticals (DHA:BEACONPHAR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beacon Pharmaceuticals PLC (DHA:BEACONPHAR) » Definitions » EV-to-Revenue

Traded in Other Exchanges

N/A

Address

9/B/2, Toyenbee Circular Road, Motijheel C/A, Beacon Business Centre, Dhaka, BGD, 1223

Website

https://www.beaconpharma.com.bd

Beacon Pharmaceuticals PLC manufactures and markets pharmaceutical products. Its products are used in various therapeutic areas, such as anticancer, cardiovascular, gastrointestinal, antibiotics, anti-coagulants, protein supplements, and muscle relaxants. The company exports its products to Europe, America, Australia, Africa, and Asia. The company's products can be segmented as General, Chronic Care, Oncology, and Biotech products.

Beacon Pharmaceuticals (DHA:BEACONPHAR) Headlines

No Headlines